SG Americas Securities
IMNM icon

SG Americas Securities’s Immunome IMNM Stock Holding History

SG Americas Securities’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$787K Sell
35,970
-126,198
-78% -$2.81M ﹤0.01% 1921
2025
Q4 		$3.48M Buy
162,168
+153,399
+1,749% +$2.69M ﹤0.01% 1250
2025
Q3 		$103K Buy
+8,769
New +$87.2K ﹤0.01% 3070
2025
Q2 		– Sell
-26,599
Closed -$179K – 3249
2025
Q1 		$179K Buy
+26,599
New +$255K ﹤0.01% 2613
2024
Q4 		– Sell
-72,627
Closed -$1.06M – 3351
2024
Q3 		$1.06M Sell
72,627
-17,877
-20% -$254K ﹤0.01% 1043
2024
Q2 		$1.09M Buy
+90,504
New +$1.42M 0.01% 1268

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

SG Americas Securities's IMNM Position: Q1 2026 in Review

SG Americas Securities reduced its Immunome (IMNM) stake by 78% in Q1 2026, selling an estimated $2.81M and leaving 35,970 shares worth $787K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

SG Americas Securities first reported a position in IMNM in Q2 2024 and has held it in 6 quarters since. The position peaked at $3.48M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • SG Americas Securities held 35,970 shares of Immunome worth $787K as of Q1 2026.
  • SG Americas Securities sold 126,198 Immunome shares in Q1 2026, an estimated $2.81M.
  • Immunome made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #1921 holding.
  • SG Americas Securities first reported a position in Immunome in Q2 2024 and has held it in 6 quarters since.
  • SG Americas Securities's Immunome position peaked at $3.48M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.